| Literature DB >> 26467759 |
Belinda Wright1, Katrina Morris2, Catherine E Grueber3,4, Cali E Willet5, Rebecca Gooley6, Carolyn J Hogg7, Denis O'Meally8, Rodrigo Hamede9, Menna Jones10, Claire Wade11, Katherine Belov12.
Abstract
BACKGROUND: The Tasmanian devil (Sarcophilus harrisii) has undergone a recent, drastic population decline due to the highly contagious devil facial tumor disease. The tumor is one of only two naturally occurring transmissible cancers and is almost inevitably fatal. In 2006 a disease-free insurance population was established to ensure that the Tasmanian devil is protected from extinction. The insurance program is dependent upon preserving as much wild genetic diversity as possible to maximize the success of subsequent reintroductions to the wild. Accurate genotypic data is vital to the success of the program to ensure that loss of genetic diversity does not occur in captivity. Until recently, microsatellite markers have been used to study devil population genetics, however as genetic diversity is low in the devil and potentially decreasing in the captive population, a more sensitive genotyping assay is required.Entities:
Mesh:
Year: 2015 PMID: 26467759 PMCID: PMC4607143 DOI: 10.1186/s12864-015-2020-4
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Characteristics of all amplicons used in genotyping assay. Detailed results for individual SNPs within all non-immune loci included in the final assay is provided in the Additional file 1: Tables S1 and S2
| Amplicon | Target variation | Chra | Length (bp) | No. of SNPs | No. of SNPs not in HWE | No. of haplotypes |
|---|---|---|---|---|---|---|
| AGA | Neutral | 6 | 9352 | 34 | 2 (6 %) | 2 |
| CCLD5/6b | Chemokine | 4 | 8209 | 25 | 22 (88 %) | 18 |
| CX3Cb | Chemokine | 1 | 9425 | 3 | 1 (33 %) | 6 |
| DIG12b | NK receptor | 3 | 6351 | 15 | 0 (0 %) | 3 |
| DIG24b | NK receptor | 3 | 6809 | 1 | 1 (100 %) | 2 |
| DRD5 | Dopamine receptor | 6 | 7885 | 1 | 0 (0 %) | 2 |
| ERN2 | Pro-apoptotic | 2 | 10,165 | 17 | 17 (100 %) | 2 |
| FOXA2 | Neutral | 1 | 10,122 | 39 | 4 (10 %) | 29 |
| IL17Bb | Interleukin | 1 | 5717 | 20 | 1 (5 %) | 2 |
| IL22F1b | Interleukin | 1 | 6531 | 3 | 2 (67 %) | 3 |
| KIT | Neutral | 2 | 8356 | 2 | 1 (50 %) | 3 |
| NF2 | Neutral | 2 | 9312 | 41 | 1 (2 %) | 3 |
| PLEKHM3 | Neutral | 3 | 10,034 | 16 | 2 (13 %) | 5 |
| RAB27A | Neutral | 1 | 10,077 | 2 | 0 (0 %) | 3 |
| TGFB1b | Cytokine | 3 | 2649 | 2 | 0 (0 %) | 3 |
| TLR3b | Toll-like receptor | 6 | 7663 | 32 | 4 (13 %) | 6 |
| UNC13B | Neutral | 2 | 9687 | 14 | 0 (0 %) | 3 |
| Total | 138,344 | 267 | 58 | 95 |
Nb. Amplicons are named according to nearest annotated gene: amplicons are not necessarily targeting the gene they are named for
aChromosome as indicated by Tasmanian devil reference genome v7.1 [32] however recent work has identified that chromosomes 1 and 2 were mis-identified [50]
bIndicates immune-targeted amplicon [40]
Fig. 1Numbers of individuals within each range of heterozygosity level for 302 Tasmanian devils within the insurance population. Three devils excluded as < 30 SNP loci successfully genotyped
Pedigree results for all genotyped offspring
| Facility/Group | No. of offspring | Potential dams | Potential sires | No of loci genotyped | Average % missing gts | Comments |
|---|---|---|---|---|---|---|
| 1/1 | 2 | 1 known | 2 | 164 | 0.51 | All resolved |
| 1/2 | 2 | 1 known | 2 | 164 | 0.61 | All resolved |
| 1/3 | 4 | 1 known | 4 | 164 | 0.60 | One unresolved- two sires possible |
| 1/4 | 4 | 1 known | 5 | 164 | 0.60 | All resolved |
| 1/5 | 7 | 4 | 4 | 164 | 0.52 | One unresolved- two dams and two sires possible |
| 1/6 | 4 | 1 known | 4 | 164 | 0.70 | All resolved |
| 2/1 | 8 | 5 | 8 | 192 | 0.22 | Exclusions only- full-sibs and half sibs amongst candidate parents, 1 dam failed genotyping |
| 2/2 | 13 | 5 known | 8 | 192 | 0.24 | Exclusions only- half-sibs amongst candidate sires, no sample for 1 known dam |
| 3/1 | 5 | 3 | 5 | 192 | 0.29 | Exclusions only- full- and half-sibs amongst candidate sires |
| 4/1 | 6 | 3 | 12 | 192 | 0.26 | Exclusions only- half-sibs amongst candidate sires and no sample for one candidate dam |
| 5/1 | 11 | 8 | 6 | 192 | 0.28 | Exclusions only- half-sibs amongst candidate parents |
Nb. Number of loci differ as trios from breeding facility 1 were genotyped in the first sequencing run whereas trios from breeding facilities 2–5 were sequenced in runs 2, 3 and 4 with a refined marker set. Known dams are according to information provided from studbook management
Fig. 2Workflow of the development of SNP-based genotyping assay